Stephen Byrn, Pamela Smith, David Engers Comparability intended to describe the sameness of amorphous materials can be assessed in a scientifically and pharmaceutically meaningful way. More specifically, it addresses how amorphous drug substances or Read more
Stephen Byrn, David Engers, Pamela Smith In the modern landscape of pharmaceutical development, it is increasingly understood that a medicine is more than just a molecule because the solid form of an active pharmaceutical Read more
Improved Pharma contributes to dual publications detailing the successful recovery and analysis of a metastable form of Ritonavir space-generated, and the single crystal growth and structure solution of Nirmatrelvir Form 2. WEST LAFAYETTE, Ind., Read more
Using Orthogonal Techniques to Probe for Detectable Crystalline API in Amorphous Dispersions WEST LAFAYETTE, Ind., April 21, 2026 /PRNewswire/ -- Detecting crystalline domains in amorphous materials can be critical for shelf-life stability of pharmaceuticals. Read more
Dissolution-Instrument-Based Strategies to De-Risk and Accelerate Pharmaceutical Development WEST LAFAYETTE, Ind., Feb. 11, 2026 /PRNewswire/ -- Improved Pharma, a leader in pharmaceutical research and solid-state chemistry, is pleased to announce a significant upgrade to its analytical Read more
Steve Byrn and David Engers Improved Pharma Feb. 11, 2026 Improved Pharma has recently expanded its dissolution capabilities by installing a fully automated Agilent 708-DS dissolution apparatus paired with the 850-DS autosampler. This capability Read more
Expanded solid-state characterization services now deliver advanced X-ray diffraction, expert interpretation, and regulatory-ready data for market authorization and patents. WEST LAFAYETTE, Ind., Feb. 9, 2026 /PRNewswire/ -- Improved Pharma is pleased to announce the expansion of Read more
Authors Jared Smit, David Engers, Steve Byrn In modern small-molecule development, solid-state characterization is far more than a routine analytical task.(Byrn, Zografi et al. 2025) It defines the manufacturable form of an API, supports Read more
WEST LAFAYETTE, Ind., Jan. 27, 2026 /PRNewswire/ -- Improved Pharma is pleased to share that our research on the crystal structure of Ritonavir Form IV has been published in the highly reputable and peer-reviewed journal, Crystal Read more
The updated second edition delivers expanded insights into solid-state pharmaceutical materials, reflecting major scientific and regulatory advances in drug development. WEST LAFAYETTE, Ind., Jan. 7, 2026 /PRNewswire/ -- Improved Pharma is proud to announce the release Read more
